Table 1.

Recommended tests for patients with T-PLL

AssessmentsGeneral practiceTrials
To establish diagnosis   
 History, physical examination Always Always 
 Blood count and differential count Always Always 
 Bone marrow aspirate and biopsy When clinically indicated Desirable 
 Biopsy or aspirate of suspected involved site When clinically indicated Desirable 
 Immunophenotyping of blood lymphocytes Always Always 
 T-cell receptor rearrangement (TRB, TRG) Always Always 
 chromosome banding analysis Desirable Desirable 
 Fluorescence in situ hybridization (FISH) Desirable Desirable 
 Testing for HTLV Always* Always* 
Before treatment start and at response assessment   
 CIRS, physical examination, performance status Always Always 
 Blood count and differential count Always Always 
 Bone marrow aspirate and biopsy Always Always 
 Serum chemistry Always Always 
 Infectious disease status (HBV, HCV, HIV, HSV) Always Always 
 Serum lactate dehydrogenase Always Always 
 b2-microglobulin Desirable Always 
 CT scan of neck, chest, abdomen, pelvis Always Always 
 PET scans Not generally indicated Not generally indicated 
 Chest radiograph Not generally indicated Not generally indicated 
 Abdominal ultrasound Not generally indicated Not generally indicated 
 Next-generation sequencing, MRD Not generally indicated Desirable 
AssessmentsGeneral practiceTrials
To establish diagnosis   
 History, physical examination Always Always 
 Blood count and differential count Always Always 
 Bone marrow aspirate and biopsy When clinically indicated Desirable 
 Biopsy or aspirate of suspected involved site When clinically indicated Desirable 
 Immunophenotyping of blood lymphocytes Always Always 
 T-cell receptor rearrangement (TRB, TRG) Always Always 
 chromosome banding analysis Desirable Desirable 
 Fluorescence in situ hybridization (FISH) Desirable Desirable 
 Testing for HTLV Always* Always* 
Before treatment start and at response assessment   
 CIRS, physical examination, performance status Always Always 
 Blood count and differential count Always Always 
 Bone marrow aspirate and biopsy Always Always 
 Serum chemistry Always Always 
 Infectious disease status (HBV, HCV, HIV, HSV) Always Always 
 Serum lactate dehydrogenase Always Always 
 b2-microglobulin Desirable Always 
 CT scan of neck, chest, abdomen, pelvis Always Always 
 PET scans Not generally indicated Not generally indicated 
 Chest radiograph Not generally indicated Not generally indicated 
 Abdominal ultrasound Not generally indicated Not generally indicated 
 Next-generation sequencing, MRD Not generally indicated Desirable 

CIRC, cumulative illness rating scale; HBV, hepatitis B virus; HCV, hepatitis C virus; HSC, herpes simplex viruses; HTLV, human T-cell leukemia-lymphoma virus.

*

In patients from endemic countries.

Before treatment start.

To confirm a remission.

Close Modal

or Create an Account

Close Modal
Close Modal